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ABSTRACT
Background: Streptococcus anginosus subsp. anginosus (SAA) is one of the opportunistic
pathogens in humans that inhabits the oral cavity. The type strain of SAA, NCTC10713T,
showed clear β-hemolysis on blood agar plates, and the sole β-hemolytic factor revealed two
streptolysin S (SLS) molecules. SLS is well known as the peptide hemolysin produced from the
human pathogen S. pyogenes and shows not only hemolytic activity on erythrocytes but also
cytotoxic activity in cell culture lines in vitro and in vivo, such as in a mouse infection model.
However, no cytotoxic activity of SLS produced from β-hemolytic SAA (β-SAA) has been
reported so far. Objective and Design: In this study, the SLS-dependent cytotoxicity of the β-
SAA strains including the genetically modified strains was investigated in vitro. Results: The
SLS-producing β-SAA showed cytotoxicity in human cell culture lines under the co-cultivation
condition and it was found that this cytotoxicity was caused by the SLS secreted into the
extracellular milieu. Conclusion: The results from this study suggest that the SLS produced
from β-SAA might indicate the cytotoxic potential similar to that of the SLS from S. pyogenes
and the SLS-producing β-SAA would be recognized as “a wolf in sheep’s clothing” More
attention will be paid to the pathogenicity of β-hemolytic Anginosus group streptococci.
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The Anginosus group of streptococci (AGS) is a group of
streptococcal strains that inhabit the oral cavity in
humans. AGS is composed of three species including
five sub-species: Streptococcus anginosus subsp. angino-
sus (SAA) and subsp. whileyi, S. constellatus subsp. con-
stellatus, subsp. pharyngis, and subsp. viborgensis, and
S. intermedius [1]. More recently, the new subspecies of
S. anginosus (S. anginosus genomosubsp. vellorensis) was
tentatively advocated from multilocus sequence analysis
(MLSA), and the type strain of SAA (NCTC10713T =
SK52) was clustered within the S. anginosus gssp. vellor-
ensis [2]. So, the reconsideration of the type strains of
S. anginosus subspecies might be done in the near future.
AGS is recognized as an opportunistic pathogen in
humans, and their pathogenicity has been thought to
be low compared to that of the typical human pathogens
of Group A streptococcus (S. pyogenes, GAS), Group
B streptococcus (S. agalactiae, GBS), and pneumococcus
(S. pneumoniae). However, in recent years, studies have
shown the pathogenic potential of AGS in humans, such
as abscess formation and infectious endocarditis [3–8].
These reports highlight the need for us to re-consider the
pathogenic potential of AGS against human.
The pathogenic streptococcal strains produce var-
ious virulence factors. One of the representatives is
hemolysin. Among the strains belonging to AGS,
there are strains that show clear β-hemolysis on blood-
agar plate culture. Based on the results from our labora-
tory and those of other research groups, two kinds of β-
hemolytic factors were reported for AGS. One is the
intermedilysin, a protein hemolysin belonging to the
family of cholesterol-dependent cytolysins (CDCs)
secreted by S. intermedius [9], and the other is the
streptolysin S (SLS), a peptide hemolysin produced by
β-hemolytic AGS except S. intermedius [10–12]. SLS
has been a long-established peptide hemolysin secreted
from a human pathogen strain of S. pyogenes [13,14],
and is reported to be produced as a post-translationally
modified product from the precursor encoded by the
sag operon on the AGS genome. Typical sag operons
such as S. pyogenes are composed of nine genes.
However, the sag operon in the genome of β-
hemolytic SAA (β-SAA) is composed of 10 genes
including two SLS-propeptide precursors encoding
genes, sagA1 and sagA2 [10]. According to our previous
report, each of the transcriptional products from sagA1
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and sagA2 functions as a hemolysin and are secreted
into their extracellular milieu during growth [10].
In S. pyogenes, the SLS produced is known to be
a virulence factor similar to the pore-forming protein
hemolysin streptolysin O, and much research was
reported on this topic in the middle of the 1960’s and
from the late 1970’s to the early 1980’s. However, pos-
sibly due to the questionable molecular properties of
SLS (e.g., low or no antigenicity and difficulty in pur-
ification), the research on SLS temporarily stagnated in
the 1990’s. After the year 2000, the situation improved
due to the discovery of the genes for the biosynthesis of
SLS and their secretion [15]. As a result, many investi-
gations were conducted and SLS was recognized as the
virulence factor of S. pyogenes. For example, the func-
tions of SLS identified include the inhibition of neutro-
phil recruitment during the early stages of infection
[16,17], translocation across the epithelial barrier [18],
contribution of GAS evasion from immune cell killing,
local tissue damage, and mortality of mouse [19], pro-
motion of programmed cell death and enhancement of
inflammatory signaling in epithelial keratinocytes [20],
inhibition of neutrophil recruitment and systemic
infection [21], and direct activation of nociceptor neu-
rons and production of pain [22]. In addition, by con-
tribution from the dramatic evolution of next-
generation sequencing, the presence of the genes encod-
ing SLS-related peptides in the Gram-positive bacteria
besides S. pyogenes was also reported. These include the
SLS-related peptide hemolysin secreted from
Streptococcus iniae [23], perfringolysin S secreted from
Clostridium perfringens [24], and listeriolysin
S produced from Listeria monocytogenes [25].
For the SLS secreted from the β-hemolytic AGS
strains, their function as the hemolytic factor was
reported for β-SAA and other β-hemolytic AGS strains
[10–12]. However, the cytotoxic potential of the SLS
from β-SAA is still inconclusive. The absence of SLS-
dependent cytotoxicity of β-SAA against the human cell
culture line THP-1 and human granulocytes was
reported [26]. However, we had reported previously
that the culture supernatant of the β-hemolytic
S. constellatus subsp. constellatus strain W277 showed
cytotoxicity to the human hepatocellular carcinoma cell
culture line HepG2 [12]. Moreover, in our investigation
on the SLS from β-hemolytic AGS strains, we had not
ruled out the cytotoxic potential of the SLS secreted
from these strains.
Based on the investigation on the SLS produced from
β-SAA, we had confirmed the SLS-dependent cytotoxi-
city of β-SAA in human cell culture lines in vitro. In this
study, in order to investigate the mechanism of the SLS-
dependent cytotoxicity of β-SAA, we used the β-
hemolysis and non-hemolysis strains of SAA,
NCTC10713T andNCTC11169, respectively. In addition,
the genetically modified strains derived from
NCTC10713T such as a non-hemolytic NCTC10713T
derivative strain lacking both the sagA1 and sagA2
genes (ΔsagAs), and its sagA1 gene-complemented strain
(psagA1) were constructed for the assay. Using these
strains, the evaluation of SLS-dependent cytotoxicity in
human cell culture lines was carried out.
Materials and methods
Bacterial strains and culture condition
In this study, the type strain of SAA, NCTC10713T,
showing SLS-dependent β-hemolysis, and a non-
hemolytic SAA strain, NCTC11169, were used. In addi-
tion to these strains, we tested certain genetically mod-
ified strains derived from NCTC10713T, an
erythromycin (erm) resistant strain carrying the
inserted erm cassette near the upstream region of the
intact sag operon, a non-hemolytic erm resistant strain
lacking both the sagA1 and sagA2 genes (ΔsagAs), and
a sagA1-gene trans-complemented strain of
ΔsagAs (psagA1). The tested strains were inoculated
into BHI broth (Becton Dickinson and Company,
Franklin Lakes, NJ) and incubated at 37°C overnight
under 5% CO2. The human oral squamous cell carci-
noma cell line HSC-2 (RCB1945, RIKEN BRC, Ibaraki,
Japan) and Eagle’s Minimum Essential Medium
(EMEM, FUJIFILM Wako, Osaka, Japan) containing
10% (v/v) of heat-inactivated fetal bovine serum
(FBS), 10% (v/v) of BHI, and 50 mM HEPES (pH 7.4)
were used for the co-cultivation. The human acute
monocytic leukemia cell line THP-1 (RCB1189,
RIKEN BRC), and RPMI1640 (FUJIFILM Wako) con-
taining 10% (v/v) of heat-inactivated FBS, 10% (v/v) of
BHI, and 50mMHEPES (pH 7.4) were also used for the
co-cultivation.
Construction of genetically modified strains
derived from S. anginosus subsp. anginosus
The genetically modified strains derived from SAA
strain NCTC10713T were generated by the homologous
recombination method in the presence of competence-
stimulating peptide (CSP) [10]. For the preparation of
the genetic fragments for recombination, specific PCR
enzymes (PrimeSTAR MAX DNA polymerase,
PrimeSTAR HS DNA polymerase, and ExTaq; TaKaRa
Bio Inc., Shiga, Japan) were selected and used according
to the manual. The genetically modified strains were
constructed as follows: An erm resistant strain was pri-
mary generated. To prepare the genetic fragment for
homologous recombination, the primer pair of
SAA_up_C3-Fw and PstI_SAA_up_C3-Bw (Table 1)
was used to amplify the upstream region of the sag
operon, and the primer pair of BamHI_SAA_dw_C3-
Fw and SAA_dw_C3-Bw (Table 1) was used to amplify
the upstream region of sagA1, using a purified genomic
DNA of NCTC10713T as the template. The fragment
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carrying the erm cassette was also amplified using the
primer pair of erm_Fw(BamHI) and erm_Bw(PstI)
(Table 1), and the purified genomic DNA from the
strain possessing the erm cassette [10] as template. As
per requirement, the amplified fragments were digested
using the restriction enzyme(s), BamHI and/or PstI, and
purified using the QIAquick Gel Extraction Kit (Qiagen,
Hilden, Germany). The purified fragments were ligated
using the DNA Ligation Kit (TaKaRa Bio Inc.), and the
genetic fragment for transformation was further ampli-
fied by PCR using the primer pair of SAA_up_C3-Fw
and SAA_dw_C3-Bw (Table 1) with the ligationmixture
as template. The transformation of NCTC10713T was
conducted under the presence of the amplified fragment
and CSP, and selected on the erythromycin containing
agar plates [10].
For the generation of the non-hemolytic
ΔsagAs strain, the fragment for homologous recombi-
nation was prepared as follows: each component was
amplified by PCR using the primer pair of SAA_up_C3-
Fw and dd1_erm_up_IF Bw (Table 1) to amplify the
upstream region of the sag operon, and the primer pair
of sagB-Fw and SA_sagB_inverse-Bw3 (Table 1) was
used to amplify the sagB using the purified genomic
DNA of the erm resistant strain as template. To prepare
the fragment for transformation, fusion PCR was per-
formed using the primer pair of SAA_up_C3-Fw and
SA_sagB_inverse-Bw3 (Table 1). The transformation
and the selection were conducted as described above.
To confirm the construction of the genetically mod-
ified strains, the genomic DNA of the candidate clone
was purified by the method reported previously [27] or
using DNAiso Reagent (TaKaRa Bio Inc.). The frag-
ment for Sanger-sequencing was amplified using high-
fidelity PCR enzyme (PrimeSTAR series, TaKaRa Bio
Inc.), and the primer pair of Seq_erm cassette-Fw and
SA_sagB probe-Bw (Table 1). The primers used for
sequencing were as follows: Seq_erm cassette-Fw,
SA_sagB probe-Bw, and sagA1-Bw (Table 1) for the
erm resistant strain; and Seq_erm cassette-Fw, In
Fusion_sagB-Bw, and SA_sagB_inverse-Bw3 (Table 1)
for the ΔsagAs strain. The sequencing was outsourced
to Eurofins Genomics K.K. (Tokyo, Japan).
Construction of the trans-complemented strain
The sagA1 gene trans-complemented strain was con-
structed based on the ΔsagAs strain using the
Streptococcus-Escherichia coli shuttle vector pMX2
[28]. Briefly, the fragment from the promoter region
of the sag operon to the end of the sagA1 gene was
digested from the vector constructed previously [10]
using EcoRI and PstI, and then inserted into the
pMX2 cut with the same restriction enzymes. The
competent cell of E. coli MC1061 was transformed
with the vector and selected. Subsequently, the vector
was purified using NucleoSpin Plasmid EasyPure
(TaKaRa Bio Inc.). After confirmation of the
sequence, the vector constructed for the sagA1-gene
trans-complementation was introduced into the
ΔsagAs strain in the presence of CSP as described
previously [10], and incubated on the horse-blood
agar plates containing 4 μg/mL of chloramphenicol,
and selected by the recovery of the β-hemolytic
character.
Viability assay of HSC-2 co-cultivated with
S. anginosus subsp. anginosus
HSC-2 was incubated in the standard cell-culture
medium for HSC-2 [EMEM containing 10% (v/v) of
heat-inactivated FBS and antibiotics (penicillin G and
streptomycin)] and inoculated with 1–2 × 104 cells/
well/100 μL in a 96-well plate, and then incubated for
1–2 d until the cells in each well reached to almost
full-confluence. The pre-cultured SAA strains were
diluted to OD600 = 0.1, 0.01, and 0.001 with the co-
cultivation medium without antibiotics, and 100 μL
of each suspension was added to HSC-2, then incu-
bated for 4–5 h at 37°C under 5% CO2 atmosphere.
After co-cultivation, the supernatant was removed
and the HSC-2 cells were washed three times using
EMEM; then the microscopic observation was con-
ducted using the IX71 inverted microscope
(Olympus, Tokyo, Japan). In addition, the viability
of the co-cultivated cells was evaluated using CCK-8
(Dojindo, Kumamoto, Japan) according to the
Table 1. Primers used in this study.
No. Name Sequence (5ʹ-3ʹ)* Purpose
1 SAA_up_C3-Fw CTTTTCAAGATCGGAAGAGC Construction of erm resistant strain
2 PstI_SAA_up_C3-Bw AAACTGCAGAGCAAACAATCCATGAGAGTCG Construction of erm resistant strain
3 BamHI_SAA_dw_C3-Fw GGGGATCCAGGGATAAATTTCTTACAGG Construction of erm resistant strain
4 SAA_dw_C3-Bw CCTATTTCACAAATATAACC Construction of erm resistant strain
5 erm_Fw(BamHI) AATGGATCCCCCGATAGCTTCCGCTATTG Construction of erm resistant strain
6 erm_Bw(PstI) GTACTGCAGCTAATAATTTATCTACATTCC Construction of erm resistant strain
7 dd1_erm_up_IF Bw TGAAAAAAATGACATAGTTTGTCCTCCTTATAAAATG Construction of ΔsagAs strain
8 sagB-Fw ATGAGAATGCTAACGAATTACTAC Construction of ΔsagAs strain
9 SA_sagB_inverse-Bw3 AGTCCTTCAACCTGTCTGGC Construction of ΔsagAs strain
10 Seq_erm cassette-Fw CTTTCTCTCACTCTGAATGG Sequencing
11 SA_sagB probe-Bw GCTTGCGGCAATGCTATGAC Sequencing
12 sagA1-Bw TTATTTTGTAGGTGCTACGG Sequencing
13 In Fusion_sagB-Bw CAGCTAATTAAGCTTTTAAAACTCCTTATTTCCAAC Sequencing
*The restriction sites are underlined.
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manual provided by manufacturer. At the end of the
co-cultivation, 0.1 N HCl was added to the cells with-
out co-cultivation and incubated for a few minutes to
prepare the dead cells to be used as background
control. After washing with standard cell-culture
medium, CCK-8 was added and incubated; then the
absorbance at 450 nm (reference wavelength at 600
nm) was measured by the plate reader Infinite M200
(TECAN, Männedorf, Switzerland).
The SLS-dependent cytotoxicity of HSC-2 under the
condition of co-cultivation with the SAA strains was
also evaluated using the Transwell (Corning Inc.,
Corning, NY). Briefly, HSC-2 was inoculated in the
bottom at 1.25 × 105 cells/well in 24-well plate and
incubated at 37°C under 5% CO2 atmosphere for 2
d. A suspension of the tested strain prepared by the co-
cultivation medium at OD600 = 0.01 was inoculated
onto the upper layer of the system and incubated for
18 h. After incubation, the upper layer was discarded
and the HSC-2 cells were stained with calcein-AM
(Dojindo), propidium iodide (Dojindo), and Hoechst
33342 (Dojindo), and then observed using IN Cell
Analyser 6000 (GE healthcare, Chicago, IL).
SLS-dependent membrane disruption of THP-1
The SLS-dependent membrane disruption of THP-1 was
also evaluated. THP-1 was re-suspended in the co-
cultivation medium for THP-1 and inoculated at
2 × 104 cells/well/50 μL in the clear-bottom-type 96-well
black plate (Greiner, Kremsmunster, Austria). Fifty
microliters of the tested strain suspension with
OD600 = 0.02, prepared by the co-cultivation medium
for THP-1, was added to the THP-1 and incubated for
4–5 h at 37°C under 5%CO2 atmosphere. The evaluation
was conducted using the CellToxTM Green Cytotoxicity
Assay (Promega, Madison, WI) as described above.
Evaluation of the cytotoxicity of culture
supernatants from β-hemolytic SAA strains
against HSC-2
For evaluation, HSC-2 cells were cultured as
described above, and the culture supernatants of the
tested strains were obtained from the log-phase cul-
ture in the co-cultivation medium. The hemolytic
activity of SLS produced in the culture supernatant
was confirmed before use for this evaluation. The
HSC-2 cells were incubated with the culture super-
natant for 1 h or 24 h at 37°C under 5% CO2 atmo-
sphere. After incubation, the culture supernatants
were discarded and 100 μL of fresh standard cell
culture medium was added to each well; then, the
viability of the cells were determined using CCK-8
(Dojindo) as mentioned above.
Time-course investigation of the membrane
disruption of culture cells by SLS
The damage to the cytoplasmic membrane of HSC-2
was evaluated using both the kits CellToxTM Green
Cytotoxicity Assay (Promega) and CytoTox-ONETM
Homogeneous Membrane Integrity Assay (Promega).
The evaluation using CellToxTM Green Cytotoxicity
Assay (Promega) was conducted according to the man-
ual of the kit. The co-cultivation of HSC-2 with the
tested strains was carried out according to the method
described above except for the use of the clear-bottom-
type 96-well black plate (Greiner) for fluorescence mea-
surement instead of the ordinary clear plate. At the end
of the co-cultivation, Lysis Solution equipped in the kit
was added to prepare the dead-cell control. After the
addition of 2 × CellTox Green Dye mix and subsequent
incubation, the fluorescence of each sample was mea-
sured in a fluorescent plate reader Infinite M200
(TECAN) at the excitation wavelength 490 nm and
emission wavelength 525 nm.
Another evaluation was also conducted using the
CytoTox-ONETM Homogeneous Membrane Integrity
Assay (Promega) according to the manual of the kit.
At the end of the co-cultivation, the dead-cell control
was prepared according to the manual. The culture
supernatant from each well (three wells per assay
condition) was collected and mixed, and then centri-
fuged (15,400 × g, 5 min). Fifty microliters of the
supernatant (triplicate per assay condition) was dis-
pensed into 96-well black plate (Corning Inc.,
Corning, NY). Then, the CytoTox-ONE Reagent
was added to each well and the plate was incubated
for the time indicated in the manual. After addition
of the Stop Solution, the fluorescence of each well was
measured in a fluorescent plate reader Infinite M200
(TECAN) at the excitation wavelength 560 nm and
emission wavelength 590 nm.
Statistical analyses
Significance of the difference between two mean
values was evaluated by Student’s t-test or Welch’s
t-test after F-test using the software R for Mac OS
X (version 3.5.1; https://cran.r-project.org/bin/
macosx/). The normality of the data was also evalu-
ated by the Kolmogorov-Smirnov test using the same
software described above.
Results
Co-cultivation with β-hemolytic S. anginosus
subsp. anginosus causes cytotoxicity in HSC-2
in vitro
The type strain of SAA, NCTC10713T, exhibits β-
hemolysis by the production of two SLS molecules
with separate amino acid sequences [9]. In order to
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investigate the SLS-dependent cytotoxicity of β-SAA,
the human oral squamous cell carcinoma cell line
HSC-2 was co-cultivated with a β-hemolytic strain
NCTC10713T or a non-hemolytic strain NCTC11169.
The co-cultivation with β-hemolytic NCTC10713T
induced obvious morphological changes, such as
a flattened morphology probably due to the leakage of
the cellular contents (Figure 1(a,b)) and bleb formation
probably due to the damage of the cytoplasmic mem-
brane (Figure 1(c,d)) as observed. Contrary to the co-
cultivation with β-hemolytic NCTC10713T, HSC-2 co-
cultivated with NCTC11169 did not show any serious
morphological changes and had intact morphology
similar to the case without co-cultivation (Figure 1(e,
f)). In the viability assay using CCK-8, the HSC-2 co-
cultivated with NCTC10713T [OD600 = 0.01 or more;
multiplicity of infection (MOI) was about 150 or more
in this condition] showed a significant (p < 0.01)
decrease in viability (Figure 1(g)) compared to the
HSC-2 without co-cultivation (designated as “w/o”).
In the case of non-hemolytic NCTC11169, the slight
but significant (p < 0.05) cytotoxicity was observed by
the co-cultivation with a higher concentration of bac-
teria [OD600 = 0.1; MOI was about 890 in this condi-
tion]. However, its cytotoxicity against HSC-2 was
clearly lower compared to that of the same amount of β-
hemolytic NCTC10713T.
In order to investigate the contribution of SLS pro-
duced from β-SAA to the cytotoxicity of HSC-2, the
viability of HSC-2 co-cultivated with the ΔsagAs strain,
the non-hemolytic isogenic mutant strain of
NCTC10713T, was also investigated. Consequently, the
co-cultivation with the ΔsagAs strain showed no cyto-
toxicity, in contrast to both the β-hemolytic strains,
NCTC10713T, and the erm resistant strain (Figure 2(a)).
Similar to the HSC-2 co-cultivated with non-hemolytic
NCTC11169 (Figure 1(e)), HSC-2 co-cultivated with the
ΔsagAs strain also did not show any morphological
changes with intact morphology of HSC-2 (Figure S1).
The SLS-dependent cytotoxicity was further investigated
by the sagA1-gene trans-complemented strain psagA1.
From the results, psagA1 also showed significant cyto-
toxicity similarly to the NCTC10713T and erm resistant
strains (Figure 2(b)). The SLS-dependent cytotoxicitywas
also investigated for the human acute monocytic leuke-
mia cell line THP-1. In the assay using the CellToxGreen
CytotoxicityAssay system (Promega), the SLS-dependent
cytotoxicity was also observed in THP-1 similarly to that
in the HSC-2 cells (Figure 3). These results indicated that
the SLS produced from β-SAA functioned as a factor
inducing cytotoxicity.
Culture supernatant of β-hemolytic S. anginosus
subsp. anginosus is not sufficient to cause acute
cytotoxicity in HSC-2
Subsequently, the cytotoxicity of the culture supernatant
of β-SAA was investigated. HSC-2 was incubated in the
Figure 1. SLS-dependent cytotoxicity of S. anginosus subsp. anginosus against human oral squamous cell carcinoma cell line
HSC-2 under co-cultivation condition. HSC-2 was co-cultivated with higher cell-density (OD600 = 0.1) (a), the magnified picture
of white square is shown as (b); and moderate cell-density (OD600 = 0.01) (c), the magnified picture of white square is shown as
(d) of β-hemolytic S. anginosus subsp. anginosus (SAA) strain NCTC10713T. HSC-2 was also co-cultivated with higher cell-density
(OD600 = 0.1) of non-hemolytic SAA strain NCTC11169 (e). Image (f) shows the intact HSC-2 without the co-cultivation with
bacteria. The morphological observation was carried out using the inverted microscope IX71 (Olympus) equipped with DP72
(Olympus) after removal of the bacterial cells. The scale bar shows 50 μm. The viability of the HSC-2 cells was also evaluated
using CCK-8 (g). The results are shown as the percentage of viability with standard deviation (SD) to 100% viable control of HSC-
2 without co-cultivation with bacteria (n = 3). The significance of the differences in the results from the cultivation without
bacteria (w/o) was evaluated by Student’s t-test or Welch’s t-test after F-test using the software R (**p < 0.01, *p < 0.05, and
“ns“ indicates ”not significant”).
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presence of the culture supernatant from a β-hemolytic
strain with sufficient hemolytic activity. After 1
h incubation, no significant acute cytotoxicity was
observed (Figure 4(a)). However, the prolonged (24 h)
incubation induced sub-acute cytotoxicity in HSC-2
(Figure 4(b)).
To evaluate further the sub-acute cytotoxicity of
the culture supernatant from β-SAA, the time course
of the culture supernatant-mediated sub-acute cyto-
toxicity was also investigated. Consequently, the
decrease of viability of HSC-2 was observed by the
24 h incubation with the culture supernatant of β-
SAA with high hemolytic activity, i.e., the culture
supernatants prepared from both 4 h and 6
h culture of NCTC10713T (Figure S2a). No decrease
in viability of HSC-2 was observed by the incubation
with the culture supernatant of non-hemolytic
ΔsagAs strain at the same incubation time (Figure
S2b). Because the growth property of both
NCTC10713T and ΔsagAs in the co-cultivation med-
ium was almost the same (Figure S2c), the decreased
viability of HSC-2 incubated with the culture super-
natant of NCTC10713T was thought to be caused by
the secreted SLS.
Cytotoxicity of β-hemolytic S. anginosus subsp.
anginosus was caused by the secreted SLS
In order to confirm whether the cytotoxicity against
HSC-2 was due to the “secreted” SLS from β-SAA,
the Transwell assay was conducted. Almost all of the
cells showed positive staining with propidium iodide
(PI) and almost negative staining with calcein-AM
after co-cultivation with the β-hemolytic strain, either
NCTC10713T or sagA1-complemented strain of
ΔsagAs, psagA1 (Figure 5). However, a contrasting
result was observed after the co-cultivation with the
ΔsagAs strain, that is, a negative staining with PI and
a positive staining with calcein-AM (Figure 5). These
results showed that the cytotoxicity of HSC-2
observed in the co-cultivation with the β-hemolytic
strains was evidently caused by the secreted SLS.
Time-course investigation of the SLS-dependent
membrane disruption in HSC-2
The time-course observation of SLS-dependent cyto-
toxicity of β-SAA was further investigated with
Figure 2. The viability of HSC-2 after co-cultivation with the tested strains. The cytotoxicity of the tested strains (ΔsagAs, sagA1
and sagA2 double deletion strain of NCTC10713T; 10713T, β-hemolytic S. anginosus subsp. anginosus NCTC10713T; erm,
erythromycin-resistant strain of NCTC10713T possessing erm cassette on the genome) against HSC-2 was evaluated using
CCK-8 (a). The viability of HSC-2 was also evaluated for the sagA1-gene trans-complemented strain of ΔsagAs, designated as
psagA1 (b). The results are shown as the percentage of viability with standard deviation (SD) to 100% viable control of the HSC-
2 without the co-cultivation with bacteria (n = 3). The significance of the differences to the result of ΔsagAs was evaluated by
Student’s t-test or Welch’s t-test after F-test using the software R (**p < 0.01).
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Figure 3. SLS-dependent cytotoxicity of THP-1 after co-
cultivation with the tested strain. THP-1 was co-cultivated
with S. anginosus subsp. anginosus strains (10713T, β-
hemolytic S. anginosus subsp. anginosus NCTC10713T;
ΔsagAs, sagA1 and sagA2 double deletion strain of
NCTC10713T; erm, erythromycin-resistant strain of
NCTC10713T possessing erm cassette on the genome;
11169, non-hemolytic S. anginosus subsp. anginosus
NCTC11169) for 4 h. Subsequently, the cytotoxicity was eval-
uated by CellTox Green Cytotoxicity Assay. The 100% live-cell
control of THP-1 without the co-cultivation with bacteria as
the background was also prepared. The dead-cell control of
THP-1 cultured with no bacteria was treated with ‘Lysis solu-
tion’ just before the end of the incubation. The results are
shown as the percentage of cytotoxicity with standard devia-
tion (SD) to 0% viable control of the THP-1 (n = 3). The
significance of differences to the result of the non-hemolytic
strain (ΔsagAs) was evaluated by Welch’s t-test after F-test
using the software R (**p < 0.01).
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a focus on the disruption to the cytoplasmic mem-
brane. For this purpose, two kinds of evaluation
systems were adopted: one is CytoTox-ONE
Homogeneous Membrane Integrity Assay to assess
the release of the lactate dehydrogenase (LDH), and
the other is CellTox Green Cytotoxicity Assay to
Figure 4. The viability of HSC-2 incubated with the culture supernatant of the tested strains. HSC-2 cells were incubated with
the culture supernatant of the tested strains (ΔsagAs, sagA1 and sagA2 double deletion strain of NCTC10713T; 10713T, β-
hemolytic S. anginosus subsp. anginosus NCTC10713T; erm, erythromycin-resistant strain of NCTC10713T possessing erm cassette
on the genome; psagA1, sagA1-gene trans-complemented strain of ΔsagAs; 11169, non-hemolytic S. anginosus subsp. anginosus
NCTC11169) as described in “Materials and methods“ and incubated for 1 h (a) or 24 h (b), then the viability was evaluated
using CCK-8. The results are shown as the percentage of viability with standard deviation (SD) to 100% of the viable control of
the HSC-2 with no treatment with bacterial culture supernatant (n = 3). The significance of differences to the result of the non-
hemolytic strain (ΔsagAs) was evaluated by Student’s t-test or Welch’s t-test after F-test using the software R (**p < 0.01 and
“ns” indicates ”not significant”).
10713T
ΔsagAs
psagA1
Calcein-AM Propidium iodide Hoechst 33342 Bright field
w/o SAA
Figure 5. The secreted SLS from β-hemolytic S. anginosus subsp. anginosus expressed cytotoxicity against HSC-2. HSC-2 was
cultured in the bottom of Transwell and each tested strain was cultured in the upper layer of Transwell for 18 h at 37°C under
5% CO2 . After co-cultivation, the cells were stained with calcein-AM, propidium iodide, and Hoechst 33342, and then observed
using IN Cell Analyser 6000. 10713T, β-hemolytic S. anginosus subsp. anginosus NCTC10713T; ΔsagAs, sagA1 and sagA2 double
deletion strain of NCTC10713T; psagA1, sagA1-gene trans-complemented strain of ΔsagAs; w/o SAA, HSC-2 without co-
cultivation. The scale bar shows 30 μm.
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assess the internalization of the small chemical com-
pound by the disruption to the cytoplasmic mem-
brane. Consequently, time-dependent disruption to
the cytoplasmic membrane was observed by co-
cultivation with the SLS-producing strain
NCTC10713T (Figure 6(a)). The cytotoxicity evalu-
ated by the CellTox Green Cytotoxicity Assay was
observed at a relatively early stage of investigation,
and obvious cytotoxicity (90% or more cell death)
was observed after 5 h or longer co-cultivation
(Figure 6(a), light-gray bar). Contrary to this, the
faint-level of cytotoxicity observed until 4 h co-
cultivation with NCTC10713T and lower cytotoxicity
began to be observed after 5 h or longer co-
cultivation as evaluated by the CytoTox-ONE
Homogeneous Membrane Integrity Assay (Figure 6
(a), dark-gray bar). No obvious cytotoxicity was
observed after the co-cultivation with the non-
hemolytic ΔsagAs strain even when evaluated in
both assay systems (Figure 6(b)). The difference in
the detectability between the two assay systems is due
to the detection principle for each assay system:
CellTox Green Cytotoxicity Assay is based on the
detection of the disruption to the cytoplasmic mem-
brane with high sensitivity by the infiltration of small
molecules across the disrupted membrane. With the
LDH release-based CytoTox-ONE Homogeneous
Membrane Integrity Assay it is difficult to detect
such SLS-dependent disruption to the cytoplasmic
membrane without large-scale pore or breakdown.
Discussion
We have been investigating the pathogenic potential
of β-hemolytic AGS, and had revealed that SLS is the
sole hemolytic factor of the β-hemolytic AGS, except
in S. intermedius that secretes the protein hemolysin
intermedilysin [10,12]. In addition, we had revealed
that the β-hemolytic S. constellatus subsp. constellatus
strain W277 showed the SLS-dependent cytotoxicity
in human hepatocellular carcinoma cell HepG2 [12].
However, another group reported that the SLS pro-
duced from SAA could not induce the cytotoxicity in
the human acute monocytic leukemia cell line THP-1
and human granulocytes [26]. According to another
report on the function of LLS, a homolog of SLS
secreted from L. monocytogenes, LLS does not con-
tribute to tissue injury and virulence in the host
organs of L. monocytogenes [29]. Thus, in order to
clarify the virulence potential of the ambiguous SLS,
particularly from β-hemolytic S. anginosus subsp.
anginosus (β-SAA), we tried to reveal the nature of
SLS from β-SAA by evaluating its contribution to the
cytotoxicity against human cell lines.
In this study, the bacterial cell number-dependent
cytotoxicity in human oral squamous cell carcinoma
cell line HSC-2 was observed under the co-cultivation
with β-SAA strains (Figure 1(g)). From the micro-
scopic observation, some blebs and the obvious mor-
phological changes, probably due to the leakage of
cellular contents by the secreted SLS, were observed
by co-cultivation with β-SAA (Figure 1(a-d)).
Although weak cytotoxicity was detected by the co-
cultivation with a higher amount of the non-
hemolytic SAA strain NCTC11169 (Figure 1(g)), no
bleb was observed (Figure 1(e)). It appears that the
weak cytotoxicity of non-hemolytic NCTC11169 may
be due to some products such as the metabolites
produced during the bacterial growth. Such SLS-
dependent cytotoxicity was also observed with the
genetically modified strains, ΔsagAs and psagA1
(Figure 2, Figure S1). Moreover, the investigation of
the complementation of the ΔsagAs strain should be
done using the strain complemented with both the
sagA1 and sagA2 genes. However, the strain comple-
mented with both sagA1 and sagA2 showed slightly
impaired growth and hemolytic activity, compared to
the parent strain NCTC10713T and other genetically
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Figure 6. The time-dependent cytotoxicity of the SLS from β-hemolytic SAA against HSC-2. HSC-2 was co-cultivated with β-
hemolytic S. anginosus subsp. anginosus NCTC10713T (a) or the non-hemolytic sagA1 and sagA2 double deletion strain of
NCTC10713T (ΔsagAs) (b). The time-dependent cytotoxicity was evaluated using the CellToxTM green cytotoxicity assay (light-
gray bar) and CytoTox-ONETM homogeneous membrane integrity assay (dark-gray bar) from 3 h to 6 h co-cultivation. The results
are shown as the percentage of cytotoxicity with standard deviation (SD) to 0% viable control (n = 3).
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modified strains (Figure S3). Due to these observa-
tions, we adopted the sagA1-gene complemented
strain psagA1 for the subsequent assays. Because
even the psagA1 strain that produces only SagA1
(one of the SLS precursors encoded by the sagA1
gene) showed the obvious cytotoxicity in HSC-2
(Figure 2(b)), it suggested that NCTC10713T causes
SLS-dependent cytotoxicity by the mature product
derived from SagA1 under the co-cultivation condi-
tion. The reason for the growth deficiency observed
in the sagA1 and sagA2 gene-complemented strain is
under investigation.
Though the culture supernatant of β-SAA could
not induce the acute cytotoxicity in HSC-2, a sub-
acute effect was observed (Figure 4, Figure S2).
Hence, the difference between the cytotoxicity against
erythrocytes and culture cells may be due to the
membrane repair mechanism equipped in the
nucleated culture cells, which is absent in the ery-
throcytes. In addition, according to the Transwell
assay (Figure 5), it was confirmed that the SLS
secreted from β-SAA acted on the culture cells and
induced the cytotoxicity in an SLS-dependent man-
ner. These results showed that the SLS secreted from
β-SAA functions as a cytotoxic factor at least in vitro.
However, a recent report described that no difference
could be observed between the hemolytic wild-type
SAA and the non-hemolytic sagB mutant, at any MOI
or time point by the LDH leakage assay for THP-1
and human granulocytes; and hence, concluded that
the S. anginosus SLS is a broad-range hemolysin with-
out cytolytic activity [26]. The difference in the
experimental design between this previous report
and ours were as follows: Firstly, the composition of
the co-cultivation medium is different. In our study,
10% (v/v) of BHI broth was added to support the
growth of the tested strain in the host cell culture
conditions. In the condition using this co-cultivation
medium, SLS is effectively produced in a growth-
dependent manner for the tested strains (Figure S3).
Hence, this condition is suitable for monitoring of
SLS-dependent cytotoxicity to the cells in vitro. In
addition, it is thought that some cellular contents
leaked from the damaged cells help the growth of
the tested strains; thus, the production of SLS is
accelerated and the cytotoxicity to the cells is
enhanced. Secondly, the method for the cytotoxicity
assay is also different. The previous report evaluated
the cytotoxicity using the LDH leakage method [26].
By this method, the cytotoxicity is detected at
a relatively later stage of the cytoplasmic membrane
disruption, which enables the leak of the cytoplasmic
protein LDH (about 35 kDa of monomer, and the
functional tetramer is about 140 kDa). However, it is
difficult to assume that the critical cytoplasmic mem-
brane disruption enabled to leak LDH which is
induced at the early stage of co-cultivation with β-
SAA, because of the cytotoxic character of SLS
thought not to be rapid and drastic as shown in
hemolysis by SLS. This idea is also supported by our
results that the secreted SLS did not show an acute
but a sub-acute effect (Figure 4). We adopted the
CellTox-Green assay system for the cytotoxicity
assay. This system enables to investigate the cytoplas-
mic membrane disruption by the infiltration of small
molecules into cells through the damaged membrane.
Using this system, the SLS-dependent cytotoxicity
was successfully detected at a relatively early stage
of co-cultivation with β-SAA, and an obvious time-
lag in the detection of cytotoxicity was observed
(Figure 6). Because the SLS-dependent cytotoxicity
of β-SAA was also observed on THP-1 using the
CellTox Green assay system (Figure 3), it was
shown that the cytotoxicity of β-SAA by SLS is not
limited to HSC-2. Based on these results, it is sug-
gested that the SLS-dependent cytotoxicity can be
established in vivo in the conditions that are suitable
for the growth of β-SAA and the SLS secretion at
their infected sites.
In S. pyogenes, it was reported that the cre
sequence existed in the promoter region of the sag
operon and it was suggested that the carbon catabo-
lite repression contributed to the process of SLS pro-
duction [30]. Recently, it has been reported that the
SLS production from β-SAA is also regulated by the
catabolite control protein CcpA [31]. These results
suggest that the conditions for SLS production will be
strongly affected by the environment in their habitats
or infected sites. In addition, because our result
showed that the SLS-dependent cytotoxicity of β-
SAA is not high and is caused by a continuous action
of secreted SLS (Figure 4), it is suggested that the
cytotoxicity of β-SAA could be established by the
continuous production of SLS at the infection sites
of β-SAA. The AGS species including SAA is thought
to be one of the opportunistic pathogens against
humans and often escape from the human normal
immune system to cause infection in vivo. Therefore,
SLS may be a risk factor for infection caused not only
by pyogenic streptococci such as S. pyogenes but also
by the SLS-producing β-hemolytic sub-group of AGS.
This prediction also suggests that suppression of SLS
production or inactivation of SLS would help us to
prevent the infective diseases caused by the SLS-
producing AGS strains.
Our present investigation on the cytotoxicity of
SLS produced from β-SAA was conducted in vitro.
However, to reveal the mechanism of SLS-
dependent cytotoxicity and virulence of β-SAA,
further investigations in vivo would be required.
In fact, it was reported that the contribution of
SLS to the bacterial survival, neutrophil infiltration,
and diffuse tissue necrosis is observed for the β-
hemolytic group G streptococcus [32], and the
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contribution of SLS and streptolysin O to the early
stages of infection and induction of necrotic lesions
in mice is also observed for S. pyogenes [33]. In
addition, it is also reported that the virulence factor
of S. pyogenes is detected in some strains of
S. anginosus [2]. Based on these accumulated recent
findings on SLS and AGS, the underestimation in
virulence of AGS, including SAA, as an opportunis-
tic pathogen may increase the risk of misdiagnosis,
prevention, and treatment of the infectious diseases
caused by such a pathogenic sub-group of AGS
producing the virulence factor(s) including the
cytotoxic factor(s) such as SLS. In order to reveal
and recognize the original pathogenicity of the β-
hemolytic sub-group of AGS, further investigation
is currently in progress.
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